Effect of Consumption of Whole-Wheat Breads on FBS, HbA1c, and Blood Lipids in Patients with Type 2 Diabetes

被引:6
|
作者
Nazari, Javad [1 ]
Yadegari, Nasrin [2 ]
Khodam, Sousan [2 ]
Almasi-Hashian, Amir [3 ]
Amini, Saeed [4 ]
机构
[1] Arak Univ Med Sci, Sch Med, Dept Pediat, Arak, Iran
[2] Arak Univ Med Sci, Deputy Hlth, Dept Nutr, Arak, Iran
[3] Arak Univ Med Sci, Dept Epidemiol, Sch Hlth, Arak, Iran
[4] Khomein Univ Med Sci, Dept Hlth Serv Management, Khomein, Iran
关键词
diabetes; dietary fiber; insulin resistance; lipid; whole grains;
D O I
10.3746/pnf.2021.26.3.269
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Whole-wheat can have positive effect on blood parameters, such as blood sugar and fat profiles, in patients with diabetic. The aim of this study was to assess the effect of whole-wheat breads on hemoglobin A1c (HbA1c) and blood lipids in patients with type 2 diabetes (T2D). The study population included men and women with T2D aged 30 years old and over in Arak, Iran. Using random sampling method, 60 patients with T2D were selected and randomly divided into control and intervention groups. After taking blood samples from the patients, the intervention group was administered 180 g of wholegrain wheat for 12 weeks. The participants were asked not to change their diets and amounts of physical activity during the study period. After 12 weeks, blood samples were taken and insulin resistance indexes, blood glucose levels, and lipid profiles were examined. The results indicated that consumption of whole-wheat bread for 12 weeks can significantly reduce body weight, and HbA1c, triglyceride, total cholesterol, and low density lipoprotein cholesterol (LDL-c) levels, and increase high density lipoprotein cholesterol (HDL-c) levels (P<0.05). However, in the control group, changes in body weight, body mass index, HbA1c, total cholesterol, HDL-c, and LDL-c levels did not significantly differ before and after the intervention period (P>0.05). As consumption of whole-wheat bread has positive effects on control of various physical and biochemical indictors in patients with diabetes, its consumption should be included in educational programs at health centers across the country.
引用
收藏
页码:269 / 274
页数:6
相关论文
共 50 条
  • [21] HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes
    Jiaqi Hu
    Huichun Hsu
    Xiaodan Yuan
    Kezheng Lou
    Cunyi Hsue
    Joshua D. Miller
    Juming Lu
    Yaujiunn Lee
    Qingqing Lou
    Journal of Endocrinological Investigation, 2021, 44 : 1229 - 1236
  • [22] HbA1c trajectories in type 2 diabetes patients: The Diabetes Care System cohort
    Nijpels, G.
    Walraven, I.
    Mast, M. R.
    Hoekstra, T.
    Jansen, A. P. D.
    van der Heijden, A. A. W.
    Rauh, S. P.
    Rutters, F.
    van 't Riet, E.
    Elders, P. J. M.
    Moll, A. C.
    Polak, B. C. P.
    Dekker, J. M.
    DIABETOLOGIA, 2014, 57 : S114 - S115
  • [23] Effect of Total Hemoglobin level on HbA1c value in Type 2 Diabetes Mellitus patients
    Narayanan, Sreedev
    Dash, Prakruti
    Mahajan, Preetam
    BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2020, 19 (01): : 110 - 113
  • [24] THE EFFECT OF DAPAGLIFLOZIN ON HEDIS PERFORMANCE MEASURES OF HBA1C IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Bell, K.
    Hardy, E.
    De Bruin, T.
    Wei, L.
    Martin, P.
    Ptaszynska, A.
    VALUE IN HEALTH, 2012, 15 (04) : A171 - A172
  • [25] HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes
    Hu, Jiaqi
    Hsu, Huichun
    Yuan, Xiaodan
    Lou, Kezheng
    Hsue, Cunyi
    Miller, Joshua D.
    Lu, Juming
    Lee, Yaujiunn
    Lou, Qingqing
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (06) : 1229 - 1236
  • [26] Achievement of individualized blood pressure and HbA1c targets in patients with hypertension and type-2 diabetes
    Schmieder, R. E.
    Tschoepe, D.
    Koch, C.
    Bramlage, P.
    Ouarrak, T.
    Gitt, A. K.
    EUROPEAN HEART JOURNAL, 2015, 36 : 539 - 539
  • [27] Relationship of baseline HbA1c and HbA1c reduction following insulin therapy in Type 2 diabetes
    Giugliano, D.
    Esposito, K.
    DIABETIC MEDICINE, 2011, 28 (02) : 247 - 247
  • [28] Effects of finerenone in patients with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability and duration of diabetes
    McGill, J. B.
    Agarwal, R.
    Anker, S. D.
    Bakris, G. L.
    Filippatos, G.
    Pitt, B.
    Ruilope, L. M.
    Birkenfeld, A. L.
    Caramori, M. L.
    Brinker, M.
    Joseph, A.
    Lage, A.
    Lawatscheck, R.
    Scott, C.
    Rossing, P.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S318 - S318
  • [29] HbA1c variability and macrovascular benefits of intensive blood pressure control in patients with type 2 diabetes
    Wang, X.
    Pei, J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [30] Is HbA1c an Equally Reliable Indicator of Low Blood Glucose in Type 1 and Type 2 Diabetes?
    Borkowska, Anna
    Szymanska-Garbacz, Elektra
    Loba, Jerzy
    Czupryniak, Leszek
    DIABETES, 2016, 65 : A542 - A543